{"id":"https://openalex.org/W2005448278","doi":"https://doi.org/10.1007/s10549-012-2126-1","title":"A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer","display_name":"A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer","publication_year":2012,"publication_date":"2012-07-05","ids":{"openalex":"https://openalex.org/W2005448278","doi":"https://doi.org/10.1007/s10549-012-2126-1","mag":"2005448278","pmid":"https://pubmed.ncbi.nlm.nih.gov/22763464","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3409367"},"language":"en","primary_location":{"id":"doi:10.1007/s10549-012-2126-1","doi":"https://doi.org/10.1007/s10549-012-2126-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10549-012-2126-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10549-012-2126-1.pdf","source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s10549-012-2126-1.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036507802","display_name":"Martin Sch\u00fcler","orcid":"https://orcid.org/0000-0002-2166-3394","observed_orcids":["https://orcid.org/0000-0002-2166-3394"]},"institutions":[{"id":"https://openalex.org/I4210119759","display_name":"Essen University Hospital","ror":"https://ror.org/02na8dn90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210119759"]},{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Schuler","raw_affiliation_strings":["Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany","institution_ids":["https://openalex.org/I4210119759","https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010064853","display_name":"Ahmad Hussein Awada","orcid":"https://orcid.org/0000-0001-7412-9163","observed_orcids":["https://orcid.org/0000-0001-7412-9163"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ahmad Awada","raw_affiliation_strings":["Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Ixelles, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Ixelles, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078567055","display_name":"Philipp Harter","orcid":"https://orcid.org/0000-0002-9663-5005","observed_orcids":["https://orcid.org/0000-0002-9663-5005"]},"institutions":[{"id":"https://openalex.org/I2800878633","display_name":"Helios Dr. Horst Schmidt Kliniken Wiesbaden","ror":"https://ror.org/03kxagd85","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2800878633","https://openalex.org/I4210138940"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philipp Harter","raw_affiliation_strings":["HSK, Dr Horst Schmidt Kliniken GmbH, Wiesbaden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HSK, Dr Horst Schmidt Kliniken GmbH, Wiesbaden, Germany","institution_ids":["https://openalex.org/I2800878633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111785329","display_name":"Jean Luc Canon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean Luc Canon","raw_affiliation_strings":["Department of Medical Oncology, Grand Hopital de Charleroi, Charleroi, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Grand Hopital de Charleroi, Charleroi, Belgium","institution_ids":["https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110479060","display_name":"Kurt Possinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738228","display_name":"Stiftung Charit\u00e9","ror":"https://ror.org/016rf0n60","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4392738228","https://openalex.org/I7877124"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kurt Possinger","raw_affiliation_strings":["Department of Hematology and Oncology, Charit\u00e9, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Charit\u00e9, Berlin, Germany","institution_ids":["https://openalex.org/I4392738228","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108479703","display_name":"Marcus Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094062","display_name":"University Medical Center of the Johannes Gutenberg University Mainz","ror":"https://ror.org/00q1fsf04","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094062"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marcus Schmidt","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University Hospital, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University Hospital, Mainz, Germany","institution_ids":["https://openalex.org/I4210094062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081718657","display_name":"Jacques De Gr\u00e8ve","orcid":"https://orcid.org/0000-0002-2389-0742","observed_orcids":["https://orcid.org/0000-0002-2389-0742"]},"institutions":[{"id":"https://openalex.org/I4210126764","display_name":"Universitair Ziekenhuis Brussel","ror":"https://ror.org/038f7y939","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210126764"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jacques De Gr\u00e8ve","raw_affiliation_strings":["Oncologisch Centrum, UZBrussel, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologisch Centrum, UZBrussel, Brussels, Belgium","institution_ids":["https://openalex.org/I4210126764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007579054","display_name":"Patrick Neven","orcid":"https://orcid.org/0000-0002-1434-9460","observed_orcids":["https://orcid.org/0000-0002-1434-9460"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Patrick Neven","raw_affiliation_strings":["Multidisciplinary Breast Centre Leuven University Hospital, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Breast Centre Leuven University Hospital, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022173747","display_name":"Luc Yves Dirix","orcid":"https://orcid.org/0000-0002-7792-9964","observed_orcids":["https://orcid.org/0000-0002-7792-9964"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luc Dirix","raw_affiliation_strings":["Oncology Centre, General Hospital St-Augustinus, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Centre, General Hospital St-Augustinus, Antwerp, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111451713","display_name":"W. Jonat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Walter Jonat","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of Kiel, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Kiel, Kiel, Germany","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044421523","display_name":"Matthias W. Beckmann","orcid":"https://orcid.org/0000-0002-8441-693X","observed_orcids":["https://orcid.org/0000-0002-8441-693X"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I4210149747","display_name":"Comprehensive Cancer Center Erlangen","ror":"https://ror.org/05jfz9645","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210149747"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias W. Beckmann","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University Breast Center Franconia, Comprehensive Cancer Center Erlangen-Nuremberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University Breast Center Franconia, Comprehensive Cancer Center Erlangen-Nuremberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053","https://openalex.org/I4210149747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046968710","display_name":"J. Sch\u00fctte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132007","display_name":"Marien Hospital D\u00fcsseldorf","ror":"https://ror.org/030qwf038","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210132007"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jochen Sch\u00fctte","raw_affiliation_strings":["Department of Oncology, Marien Hospital, D\u00fcsseldorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Marien Hospital, D\u00fcsseldorf, Germany","institution_ids":["https://openalex.org/I4210132007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017728105","display_name":"Peter Andreas Fasching","orcid":"https://orcid.org/0000-0003-4885-8471","observed_orcids":["https://orcid.org/0000-0003-4885-8471","https://orcid.org/0000-0003-1709-1079"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I4210149747","display_name":"Comprehensive Cancer Center Erlangen","ror":"https://ror.org/05jfz9645","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210149747"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter A. Fasching","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University Breast Center Franconia, Comprehensive Cancer Center Erlangen-Nuremberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University Breast Center Franconia, Comprehensive Cancer Center Erlangen-Nuremberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053","https://openalex.org/I4210149747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043042291","display_name":"Nina Gottschalk","orcid":"https://orcid.org/0000-0002-0781-028X","observed_orcids":["https://orcid.org/0000-0002-0781-028X"]},"institutions":[{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nina Gottschalk","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany","institution_ids":["https://openalex.org/I62916508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079028829","display_name":"Tatiana Besse\u2010Hammer","orcid":"https://orcid.org/0000-0002-5332-2228","observed_orcids":["https://orcid.org/0000-0002-5332-2228"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Tatiana Besse-Hammer","raw_affiliation_strings":["Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Ixelles, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Ixelles, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026524546","display_name":"Frank Fleischer","orcid":"https://orcid.org/0000-0002-9343-2683","observed_orcids":["https://orcid.org/0000-0002-9343-2683"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Frank Fleischer","raw_affiliation_strings":["Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039917291","display_name":"Sven Wind","orcid":"https://orcid.org/0009-0007-6926-8311","observed_orcids":["https://orcid.org/0009-0007-6926-8311"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sven Wind","raw_affiliation_strings":["Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109942588","display_name":"Martina Uttenreuther\u2010Fischer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martina Uttenreuther-Fischer","raw_affiliation_strings":["Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087380706","display_name":"Martine J Piccart","orcid":"https://orcid.org/0000-0001-9068-8504","observed_orcids":["https://orcid.org/0000-0001-9068-8504"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Martine Piccart","raw_affiliation_strings":["Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Ixelles, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles, Ixelles, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027231412","display_name":"Nadia Harbeck","orcid":"https://orcid.org/0000-0002-9744-7372","observed_orcids":["https://orcid.org/0000-0002-9744-7372"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Nadia Harbeck","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistr. 15, 81377, Munich, Germany","Department of Obstetrics and Gynecology, Breast Center, University of Munich Munich Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistr. 15, 81377, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Breast Center, University of Munich Munich Germany","institution_ids":["https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":19,"corresponding_author_ids":["https://openalex.org/A5027231412"],"corresponding_institution_ids":["https://openalex.org/I8204097"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":4.0907,"has_fulltext":true,"cited_by_count":90,"citation_normalized_percentile":{"value":0.94837724,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"134","issue":"3","first_page":"1149","last_page":"1159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7461000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7461000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.10440000146627426,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.08730000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":1.0},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.734000027179718},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.7089999914169312},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8339999914169312},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6200000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7409999966621399},{"id":"https://openalex.org/keywords/clinical-benefit","display_name":"clinical benefit","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8386209011077881},{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.8088699579238892},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7116196155548096},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6977551579475403},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.670802891254425},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5439766049385071},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5295613408088684},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5179835557937622},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.4863179624080658},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48555395007133484},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4260820746421814},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38968080282211304},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.32109320163726807},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.15551018714904785}],"mesh":[{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1007/s10549-012-2126-1","doi":"https://doi.org/10.1007/s10549-012-2126-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10549-012-2126-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10549-012-2126-1.pdf","source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2416822","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3409367","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22763464","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22763464","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer research and treatment","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:3409367","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3409367/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Res Treat","raw_type":"Text"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/144331","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144331","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Breast cancer research and treatment, 134 (3","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/624850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22763464","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Breast Cancer Research and Treatment, vol. 134 (3), (1149-59)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:79130","doi":null,"is_oa":false,"landing_page_url":"http://www.ncbi.nlm.nih.gov/pubmed/?term=22763464","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s10549-012-2126-1","doi":"https://doi.org/10.1007/s10549-012-2126-1","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s10549-012-2126-1","pdf_url":"https://link.springer.com/content/pdf/10.1007/s10549-012-2126-1.pdf","source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005448278.pdf","grobid_xml":"https://content.openalex.org/works/W2005448278.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W99061854","https://openalex.org/W1728803387","https://openalex.org/W1812227581","https://openalex.org/W1892496998","https://openalex.org/W1981989535","https://openalex.org/W1989339760","https://openalex.org/W2001869483","https://openalex.org/W2005303413","https://openalex.org/W2016852257","https://openalex.org/W2023188630","https://openalex.org/W2024654932","https://openalex.org/W2026595973","https://openalex.org/W2053193025","https://openalex.org/W2057282067","https://openalex.org/W2058191652","https://openalex.org/W2060099765","https://openalex.org/W2063391304","https://openalex.org/W2079113033","https://openalex.org/W2091091648","https://openalex.org/W2097255042","https://openalex.org/W2097286610","https://openalex.org/W2104975167","https://openalex.org/W2111429259","https://openalex.org/W2112099875","https://openalex.org/W2114095518","https://openalex.org/W2116161594","https://openalex.org/W2126843107","https://openalex.org/W2131994307","https://openalex.org/W2132893003","https://openalex.org/W2138095640","https://openalex.org/W2138474420","https://openalex.org/W2150883726","https://openalex.org/W2153156618","https://openalex.org/W2154841959","https://openalex.org/W2156734818","https://openalex.org/W2157840751","https://openalex.org/W2170292198","https://openalex.org/W2245135058","https://openalex.org/W2589359420","https://openalex.org/W4229525614","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2088145034","https://openalex.org/W4210879173","https://openalex.org/W7096462946","https://openalex.org/W3011091910","https://openalex.org/W1969911590","https://openalex.org/W1976527753","https://openalex.org/W1572196421","https://openalex.org/W2037927419","https://openalex.org/W2030375470","https://openalex.org/W2175378170"],"abstract_inverted_index":{"Afatinib":[0,16,221],"(BIBW":[1],"2992)":[2],"is":[3],"an":[4],"ErbB-family":[5,14],"blocker":[6],"that":[7],"irreversibly":[8],"inhibits":[9],"signaling":[10],"from":[11],"all":[12],"relevant":[13],"dimers.":[15],"has":[17],"demonstrated":[18],"preclinical":[19],"activity":[20,38,239],"in":[21,39,105,121,124,144,150,158,169,228,240],"human":[22],"epidermal":[23,68],"growth":[24,69],"factor":[25,70],"receptor":[26],"HER2":[27],"(ErbB2)-positive":[28],"and":[29,36,113,147,166,172,208,218,248,253],"triple-negative":[30,106],"xenograft":[31],"models":[32],"of":[33,64,187],"breast":[34,55,110,133,242],"cancer,":[35],"clinical":[37,98],"phase":[40,47,231],"I":[41,232],"studies.":[42],"This":[43],"was":[44,73,86,97,164],"a":[45],"multicenter":[46],"II":[48],"study":[49],"enrolling":[50],"patients":[51,125,138,143,149,176],"with":[52,126,177],"HER2-negative":[53,241],"metastatic":[54,109],"cancer":[56,111,134],"progressing":[57],"following":[58],"no":[59],"more":[60],"than":[61],"three":[62],"lines":[63],"chemotherapy.":[65],"No":[66,153],"prior":[67],"receptor-targeted":[71],"therapy":[72],"allowed.":[74],"Patients":[75],"received":[76,139],"50-mg":[77],"afatinib":[78,236],"once":[79],"daily":[80],"until":[81],"disease":[82,181],"progression.":[83],"Tumor":[84],"assessment":[85],"performed":[87],"at":[88],"every":[89],"other":[90],"28-day":[91],"treatment":[92,103,184,217],"course.":[93],"The":[94,198],"primary":[95],"endpoint":[96],"benefit":[99],"(CB)":[100],"for":[101,182,189],"\u22654":[102,183],"courses":[104,191],"(Cohort":[107,135],"A)":[108],"(TNBC)":[112],"objective":[114,154],"responses":[115,155],"measured":[116],"by":[117,215],"Response":[118],"Evaluation":[119],"Criteria":[120],"Solid":[122],"Tumors":[123],"HER2-negative,":[127],"estrogen":[128],"receptor-positive,":[129],"and/or":[130],"progesterone":[131],"receptor-positive":[132],"B).":[136],"Fifty":[137],"treatment,":[140],"including":[141],"29":[142],"Cohort":[145,151],"A":[146,171],"21":[148],"B.":[152],"were":[156,206,213,223,245],"observed":[157,201,227],"either":[159],"cohort.":[160],"Median":[161],"progression-free":[162],"survival":[163],"7.4":[165],"7.7":[167],"weeks":[168],"Cohorts":[170],"B,":[173],"respectively.":[174],"Three":[175],"TNBC":[178],"had":[179,237],"stable":[180],"courses,":[185],"one":[186],"them":[188],"12":[190],"(median":[192],"26.3":[193],"weeks;":[194],"range":[195],"18.9-47.9":[196],"weeks).":[197],"most":[199],"frequently":[200],"afatinib-associated":[202],"adverse":[203],"events":[204],"(AEs)":[205],"gastrointestinal":[207,255],"skin-related":[209],"side":[210],"effects,":[211],"which":[212],"manageable":[214,247],"symptomatic":[216],"dose":[219],"reductions.":[220],"pharmacokinetics":[222],"comparable":[224],"to":[225],"those":[226],"previously":[229],"reported":[230],"trials.":[233],"In":[234],"conclusion,":[235],"limited":[238],"cancer.":[243],"AEs":[244],"generally":[246],"mainly":[249],"affected":[250],"the":[251,254],"skin":[252],"tract.":[256]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}